STAT+: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDA

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions here.  

A huge thanks to everyone who attended the jam-packed STAT @ ASCO event last night. The bao buns were incredible. IYKYK.

Don’t forget to sign up for our ASCO virtual recap on Wednesday.

Continue to STAT+ to read the full story…